BackAvadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc Current Cash

Latest current cash for AVDL: $80M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$79.81M
179.24% YoYΔ $51.23M vs prior year quarter

Peer trimmed avg / median

Loading

Avadel Pharmaceuticals plc Current Cash History

Loading

Avadel Pharmaceuticals plc vs. peers: Current Cash Comparison

Loading

Avadel Pharmaceuticals plc Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Avadel Pharmaceuticals plc (AVDL) FAQ

Avadel Pharmaceuticals plc (AVDL) currently reports a current cash of $80M as of September 2025. That compares with $29M in the prior-year period — up 179.2% year over year. Use the charts on this page to explore Avadel Pharmaceuticals plc's current cash history and peer comparisons.

Avadel Pharmaceuticals plc's current cash increased from $29M to $80M — a 179.2% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avadel Pharmaceuticals plc reported $80M in current cash as of September 2025. That compares with $29M in the prior-year period — up 179.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $80M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avadel Pharmaceuticals plc, and consider following AVDL for alerts when major investors trade the stock.

Avadel Pharmaceuticals plc is classified in the Healthcare sector. On current cash, it currently shows $80M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVDL with unrelated industries.